Literature DB >> 12835217

Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.

Gil Salles1, Sergio Xavier, Andrea Sousa, Alejandro Hasslocher-Moreno, Claudia Cardoso.   

Abstract

BACKGROUND: QT interval parameters are potential prognostic markers of arrhythmogenicity risk and cardiovascular mortality and have never been evaluated in Chagas' disease. METHODS AND
RESULTS: Outpatients (738) in the chronic phase of Chagas' disease were enrolled in a long-term follow-up study. Maximal heart rate-corrected QT (QTc) and T-wave peak-to-end (TpTe) intervals and QRS, QT, JT, QTapex, and TpTe dispersions and variation coefficients were measured manually and calculated from 12-lead ECGs obtained on admission. Clinical, radiological, and 2-dimensional echocardiographic data were also recorded. Primary end points were all-cause, Chagas' disease-related, and sudden cardiac mortalities. During a follow-up of 58+/-39 months, 62 patients died, 54 of Chagas' disease-related causes and 40 suddenly. Multivariate Cox survival analysis revealed that the QT-interval dispersion (QTd) (hazard ratio, 1.45; 95% confidence interval, 1.29 to 1.63; P<0.001, for 10-ms increments) and left ventricular (LV) end-systolic dimension (hazard ratio, 1.36; 95% confidence interval, 1.21 to 1.53; P<0.001, for 5-mm increments) were the strongest independent predictors for all end points. The maximum QTc interval (QTcmax) could substitute for QTd with a worse predictive performance. Other predictors were heart rate, presence of pathological Q waves, frequent premature ventricular contractions (PVCs), and isolated left anterior fascicular block (LAFB) on the ECGs. Kaplan-Meier survival curves demonstrated that a QTd > or =65 ms or a QTcmax > or =465 ms1/2 discriminated the 2 groups with significantly different prognoses.
CONCLUSIONS: Electrocardiographic QTd and echocardiographic LV end-systolic dimension were the most important mortality predictors in patients with Chagas' disease. Heart rate, the presence on ECG of pathological Q waves, frequent PVCs, and isolated LAFB refined the mortality risk stratification.

Entities:  

Mesh:

Year:  2003        PMID: 12835217     DOI: 10.1161/01.CIR.0000079174.13444.9C

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

1.  Changes of QT Dispersion in Hemodialysis Patients after Administrating Zhigancao Decoction ().

Authors:  Yan-Qing Tong; Min Sun; Chun-Jie Hu; Dong-Kai Zhao
Journal:  Chin J Integr Med       Date:  2016-07-19       Impact factor: 1.978

2.  Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood.

Authors:  Paul Roddy; Javier Goiri; Laurence Flevaud; Pedro Pablo Palma; Silvia Morote; Nines Lima; Luis Villa; Faustino Torrico; Pedro Albajar-Viñas
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

3.  Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration.

Authors:  Emiliano Horacio Medei; José H M Nascimento; Roberto C Pedrosa; Luciane Barcellos; Masako O Masuda; Serge Sicouri; Marcelo V Elizari; Antonio C Campos de Carvalho
Journal:  Europace       Date:  2008-05-30       Impact factor: 5.214

4.  ECG detection of murine chagasic cardiomyopathy.

Authors:  Christopher S Eickhoff; Cade T Lawrence; John E Sagartz; Leesa A Bryant; Arthur J Labovitz; Simil S Gala; Daniel F Hoft
Journal:  J Parasitol       Date:  2010-08       Impact factor: 1.276

5.  Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction.

Authors:  Daniela do Carmo Rassi; Marcelo Luiz Campos Vieira; Ana Lúcia Martins Arruda; Viviane Tiemi Hotta; Rogério Gomes Furtado; Danilo Teixeira Rassi; Salvador Rassi
Journal:  Arq Bras Cardiol       Date:  2014-02-10       Impact factor: 2.000

Review 6.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

7.  Quantitative electrocardiographic measures, neuromuscular disorders, and survival in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Daniel Gerger; Christian Wegner; Josef Finsterer
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05       Impact factor: 1.468

Review 8.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

9.  Biomarkers and mortality in severe Chagas cardiomyopathy.

Authors:  Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

10.  Smoking Accelerates Atrioventricular Conduction in Humans Concordant with Increased Dopamine Release.

Authors:  Affan B Irfan; Claudia Arab; Andrew P DeFilippis; Pawel Lorkiewicz; Rachel J Keith; Zhengzhi Xie; Aruni Bhatnagar; Alex P Carll
Journal:  Cardiovasc Toxicol       Date:  2020-10-12       Impact factor: 3.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.